Related references
Note: Only part of the references are listed.BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells
David A. Grotsky et al.
JOURNAL OF CELL BIOLOGY (2013)
Imaging of Protein Synthesis: In Vitro and In Vivo Evaluation of 44Sc-DOTA-Puromycin
Sebastian Eigner et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
Protease-Activated Drug Development
Ki Young Choi et al.
THERANOSTICS (2012)
Quantitative Glycoproteomic Analysis of Optimal Cutting Temperature-Embedded Frozen Tissues Identifying Glycoproteins Associated with Aggressive Prostate Cancer
Yuan Tian et al.
ANALYTICAL CHEMISTRY (2011)
A new pathway that regulates 53BP1 stability implicates Cathepsin L and vitamin D in DNA repair
Ignacio Gonzalez-Suarez et al.
EMBO JOURNAL (2011)
Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome Stability
Srividya Bhaskara et al.
CANCER CELL (2010)
Cathepsin L, target in cancer treatment?
Jacqueline M. Lankelma et al.
LIFE SCIENCES (2010)
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
J-H. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Julia M. Wagner et al.
Clinical Epigenetics (2010)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
JNJ-26481585, a Novel Second-Generation Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
Janine Arts et al.
CLINICAL CANCER RESEARCH (2009)
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes
Angela Nebbioso et al.
EMBO REPORTS (2009)
Histone Deacetylase Inhibitors: Potential in Cancer Therapy
P. A. Marks et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine
David M. Bender et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
SUnSET, a nonradioactive method to monitor protein synthesis
Enrico K. Schmidt et al.
NATURE METHODS (2009)
Genetic dissection of histone deacetylase requirement in tumor cells
Michael Haberland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
Cathepsin L Proteolytically Processes Histone H3 During Mouse Embryonic Stem Cell Differentiation
Elizabeth M. Duncan et al.
CELL (2008)
Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay
Claire Bonfils et al.
CLINICAL CANCER RESEARCH (2008)
Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation
Brigitte Goulet et al.
MOLECULAR CANCER RESEARCH (2007)
Enhanced cellular uptake of Ara-C via a peptidomimetic prodrug, L-valyl-ara-C in Caco-2 cells
Eun-Pa Cheon et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Histone deacetylase 3 (HDAC3) and other class IHDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer
AJ Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis
JA Joyce et al.
CANCER CELL (2004)
A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor
B Goulet et al.
MOLECULAR CELL (2004)
A general approach to detect protein expression in vivo using fluorescent puromycin conjugates
SR Starck et al.
CHEMISTRY & BIOLOGY (2004)
Cysteine cathepsins in human cancer
C Jedeszko et al.
BIOLOGICAL CHEMISTRY (2004)
Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells
J Collette et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
P Zhu et al.
CANCER CELL (2004)
Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA
KB Glaser et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
A fluorogenic histone deacetylase assay well suited for high-throughput activity screening
D Wegener et al.
CHEMISTRY & BIOLOGY (2003)
Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers
B Vécsey-Semjén et al.
ONCOGENE (2002)
Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation
JM Mariadason et al.
GASTROENTEROLOGY (2001)
Share Paper
